Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 107 articles:
HTML format



Single Articles


    November 2022
  1. BROEKHUIS JM, James BC
    Delays in Surgery for Differentiated Thyroid Carcinomas: How Long is Reasonable, and What Questions Remain?
    J Clin Endocrinol Metab. 2022 Nov 1. pii: 6785940. doi: 10.1210.
    PubMed    


    October 2022
  2. RIVKEES SA
    Approach to the Patient: Management and the Long-Term Consequences of Graves' Disease in Children.
    J Clin Endocrinol Metab. 2022 Oct 3. pii: 6746564. doi: 10.1210.
    PubMed     Abstract available


    September 2022
  3. ANGELL TE, Kwon DI
    Finding the Balance on Extent of Initial Thyroidectomy for Low-Risk Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2022 Sep 22. pii: 6711571. doi: 10.1210.
    PubMed    


  4. PALERMO A, Sodo A, Naciu AM, Gioacchino MD, et al
    Clinical use of Raman spectroscopy improves diagnostic accuracy for indeterminate thyroid nodules.
    J Clin Endocrinol Metab. 2022 Sep 14. pii: 6697971. doi: 10.1210.
    PubMed     Abstract available


  5. PALERMO A, Cesareo R
    Response to Letter to the Editor from Xu and Yang: Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules:12-Month Results of a Randomized Trial (LARA II Study).
    J Clin Endocrinol Metab. 2022 Sep 3. pii: 6691130. doi: 10.1210.
    PubMed    


  6. ZHOU H, Wu J, Shi L, Wang Y, et al
    Analysis of delayed surgery and clinical outcomes in intermediate- and high-risk papillary thyroid cancer.
    J Clin Endocrinol Metab. 2022 Sep 3. pii: 6691129. doi: 10.1210.
    PubMed     Abstract available


    August 2022
  7. MA X, Ma X, Chin L, Zhu Z, et al
    A Novel Germline Deletion of p.C630 in RET Causes MTC and Promotes Cell Proliferation and Sensitivity to Pralsetinib.
    J Clin Endocrinol Metab. 2022;107:2636-2643.
    PubMed     Abstract available


  8. ARROYO N, Bell KJL, Hsiao V, Fernandes-Taylor S, et al
    Prevalence of Subclinical Papillary Thyroid Cancer by Age: Meta-analysis of Autopsy Studies.
    J Clin Endocrinol Metab. 2022 Aug 10. pii: 6659928. doi: 10.1210.
    PubMed     Abstract available


  9. CHEN DW, Rob FI, Mukherjee R, Giordano TJ, et al
    Variation in the diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    J Clin Endocrinol Metab. 2022 Aug 3. pii: 6653515. doi: 10.1210.
    PubMed     Abstract available


  10. CHOI JH, Lee JK, Kim W, Yu HW, et al
    Prevalence of Postoperatively-Detected High-Risk Features in 2-4cm Papillary Thyroid Cancers.
    J Clin Endocrinol Metab. 2022 Aug 1. pii: 6653085. doi: 10.1210.
    PubMed     Abstract available


    July 2022
  11. WANG X, Zheng X, Zhu J, Li Z, et al
    Radioactive iodine therapy does not improve cancer-specific survival in Hurthle cell carcinoma of the thyroid.
    J Clin Endocrinol Metab. 2022 Jul 31. pii: 6652584. doi: 10.1210.
    PubMed     Abstract available


  12. OMIDAKHSH N, Heck JE, Cockburn M, Ling C, et al
    Thyroid Cancer and Pesticide Use in a Central California Agricultural Area: A Case Control Study.
    J Clin Endocrinol Metab. 2022 Jul 26. pii: 6650257. doi: 10.1210.
    PubMed     Abstract available



  13. Correction to: Lenvatinib Targets PDGFR-beta Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights.
    J Clin Endocrinol Metab. 2022 Jul 8. pii: 6633918. doi: 10.1210.
    PubMed    


    June 2022
  14. ALZAHRANI AS, Alswailem M, Alghamdi B, Al-Hindi H, et al
    Fumarate hydratase is a novel gene for familial non-medullary thyroid cancer.
    J Clin Endocrinol Metab. 2022 Jun 25. pii: 6618018. doi: 10.1210.
    PubMed     Abstract available


  15. WANG K, Liu S, Tian Y, Liu C, et al
    PDZK1 interacting protein 1 (PDZK1IP1) promotes the progression of papillary thyroid cancer.
    J Clin Endocrinol Metab. 2022 Jun 21. pii: 6612492. doi: 10.1210.
    PubMed     Abstract available


  16. SAVVATEEVA M, Kudryavtseva A, Lukyanova E, Kobelyatskaya A, et al
    Somatic Mutation Profiling in Head and Neck Paragangliomas.
    J Clin Endocrinol Metab. 2022;107:1833-1842.
    PubMed     Abstract available


  17. TSANG V, Gill A, Gild M, Lurie B, et al
    Selpercatinib treatment of RET mutated thyroid cancers is associated with gastrointestinal adverse effects.
    J Clin Endocrinol Metab. 2022 Jun 1. pii: 6596759. doi: 10.1210.
    PubMed     Abstract available


    May 2022
  18. ELISEI R, Ciampi R, Matrone A, Prete A, et al
    Somatic Ret Indels In Sporadic Medullary Thyroid Cancer: Prevalence And Response To Selpercatinib.
    J Clin Endocrinol Metab. 2022 May 25. pii: 6591888. doi: 10.1210.
    PubMed     Abstract available


  19. GLASGOW C, Lau EYC, Aloj L, Harper I, et al
    An Approach to a Patient With Primary Hyperparathyroidism and a Suspected Ectopic Parathyroid Adenoma.
    J Clin Endocrinol Metab. 2022;107:1706-1713.
    PubMed     Abstract available


  20. VIOLA D, Poma AM, Elisei R, Basolo F, et al
    Response to Letter to the Editor From Green and Gosmanov: "Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients' Clinical Management".
    J Clin Endocrinol Metab. 2022;107:e2653-e2654.
    PubMed    


  21. GREEN M, Gosmanov AR
    Letter to the Editor From Green and Gosmanov: "Tall Cell Percentage Alone in PTC Without Aggressive Features Should Not Guide Patients' Clinical Management".
    J Clin Endocrinol Metab. 2022;107:e2647-e2648.
    PubMed    


  22. SOE MH, Chiang JM, Flavell RR, Khanafshar E, et al
    Non-iodine Avid Disease is Highly Prevalent in Distant Metastatic Differentiated Thyroid Cancer with Papillary Histology.
    J Clin Endocrinol Metab. 2022 May 12. pii: 6584960. doi: 10.1210.
    PubMed     Abstract available


  23. BURGOS N, Zhao J, Brito JP, Hoang JK, et al
    Clinician agreement on the classification of thyroid nodules ultrasound features: A survey of two endocrine societies.
    J Clin Endocrinol Metab. 2022 May 6. pii: 6581574. doi: 10.1210.
    PubMed     Abstract available


    April 2022
  24. CIAMPI R, Romei C, Ramone T, Matrone A, et al
    Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2022 Apr 26. pii: 6574259. doi: 10.1210.
    PubMed     Abstract available


  25. VINCZE S, Peters NV, Kuo CL, Brown TC, et al
    GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism.
    J Clin Endocrinol Metab. 2022;107:e2021-e2026.
    PubMed     Abstract available


  26. PAPPA T, Ahmadi S, Bikas A, Hwang S, et al
    Thyroid nodule shape independently predicts risk of malignancy.
    J Clin Endocrinol Metab. 2022 Apr 19. pii: 6570820. doi: 10.1210.
    PubMed     Abstract available


  27. PAPARODIS RD, Karvounis E, Bantouna D, Chourpiliadis C, et al
    Large, slowly growing, benign thyroid nodules frequently coexist with synchronous thyroid cancers.
    J Clin Endocrinol Metab. 2022 Apr 18. pii: 6570003. doi: 10.1210.
    PubMed     Abstract available


  28. ULLMANN TM, Duh QY
    Isolated Lateral Neck Nodal Metastases in Patients with Papillary Thyroid Cancer: Does Cervical Compartment Matter?
    J Clin Endocrinol Metab. 2022 Apr 12. pii: 6567539. doi: 10.1210.
    PubMed    


  29. HUANG L, Feng X, Yang W, Li X, et al
    Appraising the effect of potential risk factors on thyroid cancer: A Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Apr 2. pii: 6562772. doi: 10.1210.
    PubMed     Abstract available


    March 2022
  30. ZHAO ZL, Wei Y, Peng LL, Li Y, et al
    Recurrent Laryngeal Nerve Injury in Thermal Ablation of Thyroid Nodules - Risk Factors and Cause Analysis.
    J Clin Endocrinol Metab. 2022 Mar 21. pii: 6551221. doi: 10.1210.
    PubMed     Abstract available


  31. BOUCAI L, Tuttle RM
    Letter to the Editor from Boucai, L and Tuttle, RM: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer".
    J Clin Endocrinol Metab. 2022 Mar 9. pii: 6545312. doi: 10.1210.
    PubMed    


  32. XING M
    Response to Letter to the Editor from Boucai and Tuttle: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer".
    J Clin Endocrinol Metab. 2022 Mar 9. pii: 6545262. doi: 10.1210.
    PubMed    


    February 2022
  33. WENG HY, Yan T, Qiu WW, Fan YB, et al
    The prognosis of skip metastasis in papillary thyroid microcarcinoma is better than that of continuous metastasis.
    J Clin Endocrinol Metab. 2022 Feb 25. pii: 6537119. doi: 10.1210.
    PubMed     Abstract available


    January 2022
  34. ALEXANDER EK
    Novel Genomic Roadmaps and Their Clinical Translation Ahead.
    J Clin Endocrinol Metab. 2022;107:e886-e887.
    PubMed    


  35. HAY ID, Lee RA, Charboneau JW
    Efficacy of ethanol ablation in long-term local control of neck nodal metastases in adult papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2022 Jan 14. pii: 6507732. doi: 10.1210.
    PubMed    


  36. JANKOVIC MILJUS J, Guillen-Sacoto MA, Makiadi-Alvarado J, Wert-Lamas L, et al
    Circulating MicroRNA Profiles as Potential Biomarkers for differentiated thyroid cancer recurrence.
    J Clin Endocrinol Metab. 2022 Jan 11. pii: 6503735. doi: 10.1210.
    PubMed     Abstract available


    December 2021
  37. STAN MN, Papaleontiou M, Schmitz JJ, Castro MR, et al
    Non-surgical management of thyroid nodules - the role of ablative therapies.
    J Clin Endocrinol Metab. 2021 Dec 25. pii: 6483061. doi: 10.1210.
    PubMed     Abstract available


  38. ROTONDI M, Chiovato L
    Pre-existing or concomitant thyroiditis in papillary thyroid cancer: Something more than a mere issue of timing?
    J Clin Endocrinol Metab. 2021 Dec 20. pii: 6470727. doi: 10.1210.
    PubMed    


  39. FRICH PS, Sigstad E, Berstad AE, Holgersen KF, et al
    Long-Term Efficacy of Ethanol Ablation as Treatment of Metastatic Lymph Nodes from Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2021 Dec 18. pii: 6469671. doi: 10.1210.
    PubMed     Abstract available


  40. ASAMOAH EO, Caraballo G, Castro MR
    Identifying and addressing Health disparities in Thyroid Cancer Care.
    J Clin Endocrinol Metab. 2021 Dec 6. pii: 6454343. doi: 10.1210.
    PubMed    


    November 2021
  41. BOUCAI L, Seshan V, Williams M, Knauf JA, et al
    Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score.
    J Clin Endocrinol Metab. 2021 Nov 23. pii: 6433608. doi: 10.1210.
    PubMed     Abstract available


  42. NIETO HR, Thornton CEM, Brookes K, de Menezes AN, et al
    Recurrence of Papillary Thyroid Cancer: A Systematic Appraisal of Risk Factors.
    J Clin Endocrinol Metab. 2021 Nov 16. pii: 6429719. doi: 10.1210.
    PubMed     Abstract available


  43. WEI Y, Zhao ZL, Wu J, Peng LL, et al
    Response to Letter to the Editor from [Shijie Yang]: (Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study).
    J Clin Endocrinol Metab. 2021 Nov 14. pii: 6427797. doi: 10.1210.
    PubMed    


  44. YANG S, Xu X
    Letter to the Editor from [Shijie Yang]: (Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study).
    J Clin Endocrinol Metab. 2021 Nov 14. pii: 6427798. doi: 10.1210.
    PubMed    


  45. LI H, Zhou X, Wang G, Hua D, et al
    CAR-T cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Nov 9. pii: 6423845. doi: 10.1210.
    PubMed     Abstract available


    October 2021
  46. ROH E, Noh E, Hwang SY, Kim JA, et al
    Increased risk of type 2 diabetes in patients with thyroid cancer after thyroidectomy: A nationwide cohort study.
    J Clin Endocrinol Metab. 2021 Oct 28. pii: 6413717. doi: 10.1210.
    PubMed     Abstract available


  47. RADHAKRISHNAN A, Reyes-Gastelum D, Abrahamse P, Gay B, et al
    Physician specialties involved in thyroid cancer diagnosis and treatment: Implications for improving healthcare disparities.
    J Clin Endocrinol Metab. 2021 Oct 26. pii: 6411790. doi: 10.1210.
    PubMed     Abstract available


  48. KOH J, Zhang R, Roman S, Duh QY, et al
    Ex Vivo Intact Tissue Analysis Reveals Alternative Calcium-sensing Behaviors in Parathyroid Adenomas.
    J Clin Endocrinol Metab. 2021;106:3168-3183.
    PubMed     Abstract available


  49. SAPONARO F, Pardi E, Mazoni L, Borsari S, et al
    Do Patients With Atypical Parathyroid Adenoma Need Close Follow-up?
    J Clin Endocrinol Metab. 2021;106:e4565-e4579.
    PubMed     Abstract available


  50. NILUBOL N
    "Cutting the Support" to improve treatment efficacy in thyroid cancer by targeting tumor microenvironment.
    J Clin Endocrinol Metab. 2021 Oct 20. pii: 6406379. doi: 10.1210.
    PubMed    


  51. BROSE MS, Panaseykin Y, Konda B, de La Fouchardiere C, et al
    A Randomized Study of Lenvatinib 18 mg Vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Oct 19. pii: 6401965. doi: 10.1210.
    PubMed     Abstract available


  52. CHANDER NR, Chidambaram S, Van Den Heede K, DiMarco AN, et al
    Correlation of pre-operative imaging findings and parathyroidectomy outcomes support NICE 2019 guidance.
    J Clin Endocrinol Metab. 2021 Oct 13. pii: 6395413. doi: 10.1210.
    PubMed     Abstract available


  53. GOLDFARB M, Christison-Lagay E, Rastatter J, Wasserman J, et al
    "Young children are not the same as adolescents when it comes to treating thyroid cancer".
    J Clin Endocrinol Metab. 2021 Oct 5. pii: 6381652. doi: 10.1210.
    PubMed    


    September 2021
  54. SINGH P, Bhadada SK, Dahiya D, Saikia UN, et al
    GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.
    J Clin Endocrinol Metab. 2021;106:e4084-e4096.
    PubMed     Abstract available


  55. POMA AM, Viola D, Macerola E, Proietti A, et al
    Tall cell percentage alone in PTC without aggressive features should not guide patients' clinical management.
    J Clin Endocrinol Metab. 2021;106:e4109-e4117.
    PubMed     Abstract available


  56. LIN S, Zhu Y, Ji C, Yu W, et al
    METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.
    J Clin Endocrinol Metab. 2021 Sep 25. pii: 6375332. doi: 10.1210.
    PubMed     Abstract available


  57. KIM BW
    Does Radioactive Iodine Therapy for Hyperthyroidism Cause Cancer?
    J Clin Endocrinol Metab. 2021 Sep 23. pii: 6374549. doi: 10.1210.
    PubMed     Abstract available


  58. DEKKER BL, Links MH, Muller Kobold AC, Swart-Busscher LG, et al
    Low iodine diet of four days is sufficient preparation for 131I therapy in differentiated thyroid cancer patients.
    J Clin Endocrinol Metab. 2021 Sep 17. pii: 6371836. doi: 10.1210.
    PubMed     Abstract available


    August 2021
  59. SINGH P, Bhadada SK, Arya AK, Saikia UN, et al
    Aberrant epigenetic alteration of PAX1 expression contributes to parathyroid tumorigenesis.
    J Clin Endocrinol Metab. 2021 Aug 28. pii: 6358989. doi: 10.1210.
    PubMed     Abstract available


  60. REDLICH A, Luster M, Lorenz K, Lessel L, et al
    Age, ATA risk group and response to therapy are prognostic factors in children with differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2021 Aug 20. pii: 6355728. doi: 10.1210.
    PubMed     Abstract available


  61. GIOVANELLA L, Garo ML, Ceriani L, Paone G, et al
    Procalcitonin as an alternative tumor marker of medullary thyroid carcinoma. A meta-analysis.
    J Clin Endocrinol Metab. 2021 Aug 12. pii: 6348893. doi: 10.1210.
    PubMed     Abstract available


  62. HAYES AR, Crawford A, Al Riyami K, Tang C, et al
    Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy.
    J Clin Endocrinol Metab. 2021 Aug 11. pii: 6348246. doi: 10.1210.
    PubMed     Abstract available


  63. LEE EK, Ahn HY, Ku EJ, Yoo WS, et al
    Cardiovascular outcomes in thyroid cancer patients treated with thyroidectomy: A meta-analysis.
    J Clin Endocrinol Metab. 2021 Aug 4. pii: 6339941. doi: 10.1210.
    PubMed     Abstract available


    July 2021
  64. CIAPPUCCINI R, Saguet-Rysanek V, Giffard F, Licaj I, et al
    PSMA expression in differentiated thyroid cancer: association with radioiodine, 18FDG uptake, and patient outcome.
    J Clin Endocrinol Metab. 2021 Jul 31. pii: 6332894. doi: 10.1210.
    PubMed     Abstract available


  65. IESATO A, Li S, Roti G, Hacker MR, et al
    Lenvatinib targets PDGFR-beta pericytes and inhibits synergy with thyroid carcinoma cells: novel translational insights.
    J Clin Endocrinol Metab. 2021 Jul 24. pii: 6327813. doi: 10.1210.
    PubMed     Abstract available


  66. KU EJ, Yoo WS, Lee EK, Ahn HY, et al
    Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2021 Jul 24. pii: 6327817. doi: 10.1210.
    PubMed     Abstract available


  67. TAO Y, Wang F, Shen X, Zhu G, et al
    BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Jul 17. pii: 6323355. doi: 10.1210.
    PubMed     Abstract available


  68. GIANI C, Torregrossa L, Ramone T, Romei C, et al
    Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Jul 3. pii: 6291802. doi: 10.1210.
    PubMed     Abstract available


  69. YANG S, Xu X
    Letter to the Editor from [Xiequn Xu]: (Laser Ablation versus Radiofrequency Ablation for thyroid nodules: Twelve-month results of a randomized trial (LARA II study)).
    J Clin Endocrinol Metab. 2021 Jul 1. pii: 6312741. doi: 10.1210.
    PubMed    


    June 2021
  70. PAULSSON JO, Rafati N, DiLorenzo S, Chen Y, et al
    Whole-genome sequencing of follicular thyroid carcinomas reveal recurrent mutations in microRNA processing subunit DGCR8.
    J Clin Endocrinol Metab. 2021 Jun 25. pii: 6309631. doi: 10.1210.
    PubMed     Abstract available


  71. RADEBE L, van der Kaay DCM, Wasserman JD, Goldenberg A, et al
    Predicting Malignancy with Pediatric Thyroid Nodules: Early Experience in Machine Learning for Clinical Decision Support.
    J Clin Endocrinol Metab. 2021 Jun 23. pii: 6308313. doi: 10.1210.
    PubMed     Abstract available


  72. MANIAKAS A, Henderson YC, Hei H, Peng S, et al
    Novel anaplastic thyroid cancer PDXs and cell lines: Expanding preclinical models of genetic diversity.
    J Clin Endocrinol Metab. 2021 Jun 19. pii: 6306517. doi: 10.1210.
    PubMed     Abstract available


  73. TIAN T, Xu Y, Zhang X, Liu B, et al
    Prognostic implications of pre-ablation stimulated Tg: a retrospective analysis of 2500 thyroid cancer patients.
    J Clin Endocrinol Metab. 2021 Jun 18. pii: 6304758. doi: 10.1210.
    PubMed     Abstract available


  74. LIMBACH AL, Sipos JA
    Indeterminate thyroid nodules: the hazy genomic landscape coming into focus.
    J Clin Endocrinol Metab. 2021 Jun 16. pii: 6303548. doi: 10.1210.
    PubMed    


  75. HENDERSON YC, Mohamed ASR, Maniakas A, Chen Y, et al
    A High-Throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2021 Jun 12. pii: 6297567. doi: 10.1210.
    PubMed     Abstract available


    May 2021
  76. HU MI, Waguespack SG, Dosiou C, Ladenson PW, et al
    Afirma Genomic Sequencing Classifier & Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules.
    J Clin Endocrinol Metab. 2021 May 19. pii: 6278308. doi: 10.1210.
    PubMed     Abstract available


  77. SUTEAU V, Seegers V, Munier M, Ben Boubaker R, et al
    G Protein-Coupled Receptors in radioiodine-refractory thyroid cancer in the Era of Precision Medicine.
    J Clin Endocrinol Metab. 2021 May 17. pii: 6277036. doi: 10.1210.
    PubMed     Abstract available


  78. PITT SC, Haymart MR
    Breaking Down or Waking Up? Psychological Distress and Sleep Disturbance in Patients with Thyroid Nodules and Cancer.
    J Clin Endocrinol Metab. 2021 May 13. pii: 6274981. doi: 10.1210.
    PubMed    


  79. RAUE F, Bruckner T, Frank-Raue K
    Similar stage-dependent survival and outcome in sporadic and hereditary medullary thyroid carcinoma.
    J Clin Endocrinol Metab. 2021 May 11. pii: 6273583. doi: 10.1210.
    PubMed     Abstract available


    April 2021
  80. VALERIO L, Guidoccio F, Giani C, Tardelli E, et al
    [ 18F]-FDG-PET/CT correlates with the response of radiorefractory thyroid cancer to lenvatinib and patients' survival.
    J Clin Endocrinol Metab. 2021 Apr 26. pii: 6253809. doi: 10.1210.
    PubMed     Abstract available


  81. LI R, Li G, Wang Y, Bao T, et al
    Psychological distress and sleep disturbance throughout thyroid nodules screening, diagnosis and treatment.
    J Clin Endocrinol Metab. 2021 Apr 8. pii: 6217326. doi: 10.1210.
    PubMed     Abstract available


    March 2021
  82. MACHENS A, Lorenz K, Weber F, Dralle H, et al
    Exceptionality of Distant Metastases in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
    J Clin Endocrinol Metab. 2021 Mar 31. pii: 6206751. doi: 10.1210.
    PubMed     Abstract available


  83. CHERELLA CE, Richman DM, Liu E, Frates MC, et al
    Predictors of Bilateral Disease in Pediatric Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Mar 29. pii: 6199870. doi: 10.1210.
    PubMed     Abstract available


  84. LIN YS, Zhang X, Wang C, Liu YQ, et al
    Long-term results of phase II trial of apatinib for progressive radioiodine refractory differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2021 Mar 26. pii: 6189101. doi: 10.1210.
    PubMed     Abstract available


  85. SEO GH, Ae Kong K, Kim BS, Seo YK, et al
    Radioactive Iodine Treatment for Children and Young Adults with Thyroid Cancer in South Korea: A Population-Based Study.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6184125. doi: 10.1210.
    PubMed     Abstract available


  86. WALLNER LP, Banerjee M, Reyes-Gastelum D, Hamilton AS, et al
    Multi-level factors associated with more intensive use of radioactive iodine for low-risk thyroid cancer.
    J Clin Endocrinol Metab. 2021 Mar 4. pii: 6158968. doi: 10.1210.
    PubMed     Abstract available


  87. XI C, Zhang Q, Song HJ, Shen CT, et al
    Pregnancy does not affect the Prognoses of Differentiated Thyroid Cancer Patients with Lung Metastases.
    J Clin Endocrinol Metab. 2021 Mar 1. pii: 6155712. doi: 10.1210.
    PubMed     Abstract available


    February 2021
  88. CHEN DW, Reyes-Gastelum D, Hawley ST, Wallner LP, et al
    Unmet Information Needs Among Hispanic Women with Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Feb 28. pii: 6154483. doi: 10.1210.
    PubMed     Abstract available


  89. LI CW, Shi X, Ma B, Wang YL, et al
    A Four Gene-based Immune Signature Predicts Dedifferentiation and Immune Exhaustion in Thyroid Cancer.
    J Clin Endocrinol Metab. 2021 Feb 28. pii: 6154371. doi: 10.1210.
    PubMed     Abstract available


  90. CESAREO R, Manfrini S, Pasqualini V, Ambrogi C, et al
    Laser Ablation versus Radiofrequency Ablation for thyroid nodules: Twelve-month results of a randomized trial (LARA II study).
    J Clin Endocrinol Metab. 2021 Feb 20. pii: 6145113. doi: 10.1210.
    PubMed     Abstract available


  91. ALEXANDER EK
    From the Tip to the Iceberg below - Evolving our Molecular Understanding of Thyroid Nodules.
    J Clin Endocrinol Metab. 2021 Feb 16. pii: 6137555. doi: 10.1210.
    PubMed    


  92. CHEN D, Tan Y, Li Z, Li W, et al
    Organoid cultures derived from patients with papillary thyroid cancer.
    J Clin Endocrinol Metab. 2021 Feb 1. pii: 6125726. doi: 10.1210.
    PubMed     Abstract available


    January 2021
  93. PANAGIOTOU G, Ghaly W, Upadhyay J, Pazaitou-Panayiotou K, et al
    Serum follistatin is increased in thyroid cancer and is associated with adverse tumor characteristics in humans.
    J Clin Endocrinol Metab. 2021 Jan 25. pii: 6119546. doi: 10.1210.
    PubMed     Abstract available


  94. DUTTA S, Tarafdar S, Mukhopadhyay P, Bhattacharyya NP, et al
    Plasma cell free DNA to differentiate malignant from benign thyroid nodules.
    J Clin Endocrinol Metab. 2021 Jan 21. pii: 6105060. doi: 10.1210.
    PubMed     Abstract available


  95. CHONG AS, Nikiforov YE, Condello V, Wald AI, et al
    Prevalence and spectrum of DICER1 mutations in adult-onset thyroid nodules with indeterminate cytology.
    J Clin Endocrinol Metab. 2021 Jan 18. pii: 6103949. doi: 10.1210.
    PubMed     Abstract available


  96. ZHANG L, Ren Z, Su Z, Liu Y, et al
    Novel recurrent altered genes in Chinese patients with anaplastic thyroid cancer.
    J Clin Endocrinol Metab. 2021 Jan 11. pii: 6082745. doi: 10.1210.
    PubMed     Abstract available


  97. MURPHY CF, Stratford N, Docherty NG, Moran B, et al
    A Pilot Study of Gut-Brain Signaling After Octreotide Therapy for Unintentional Weight Loss After Esophagectomy.
    J Clin Endocrinol Metab. 2021;106:e204-e216.
    PubMed     Abstract available


    December 2020
  98. GRANI G, Lamartina L, AlfO M, Ramundo V, et al
    Selective use of radioactive iodine therapy for papillary thyroid cancers with low or lower-intermediate recurrence risk.
    J Clin Endocrinol Metab. 2020 Dec 30. pii: 6055578. doi: 10.1210.
    PubMed     Abstract available


  99. PITT SC, Yang N, Saucke MC, Marka N, et al
    Adoption of Active Surveillance for Very Low-Risk Differentiated Thyroid Cancer in the United States: A National Survey.
    J Clin Endocrinol Metab. 2020 Dec 29. pii: 6054975. doi: 10.1210.
    PubMed     Abstract available


  100. ZHU CY, Donangelo I, Gupta D, Nguyen DT, et al
    Outcomes of Indeterminate Thyroid Nodules Managed Nonoperatively after Molecular Testing.
    J Clin Endocrinol Metab. 2020 Dec 2. pii: 6015927. doi: 10.1210.
    PubMed     Abstract available


    November 2020
  101. MOON JH, Ryu CH, Cho SW, Choi JY, et al
    Effect of initial treatment choice on 2-year quality of life in patients with low-risk papillary thyroid microcarcinoma.
    J Clin Endocrinol Metab. 2020 Nov 28. pii: 6009064. doi: 10.1210.
    PubMed     Abstract available


  102. CAPEZZONE M, Sagnella A, Pilli T, Maino F, et al
    Role of Age at Diagnosis in Defining Potential Familial Non-Medullary Thyroid Cancer in Kindreds with Only Two Affected Members.
    J Clin Endocrinol Metab. 2020 Nov 11. pii: 5974121. doi: 10.1210.
    PubMed     Abstract available


    October 2020
  103. WASSNER AJ
    Risk Stratification in Pediatric Thyroid Cancer: Growing Evidence for Individualized Therapy.
    J Clin Endocrinol Metab. 2020 Oct 30. pii: 5943497. doi: 10.1210.
    PubMed    


  104. BROOME DT, Naples R, Bailey R, Tekin Z, et al
    Use of Preoperative Imaging in Primary Hyperparathyroidism.
    J Clin Endocrinol Metab. 2020 Oct 29. pii: 5942949. doi: 10.1210.
    PubMed     Abstract available


  105. YANG S, Jin C, Xu X
    Letter to the Editor from Shijie Yang et al: US-guided Microwave Ablation of Low-Risk Papillary Thyroid Microcarcinoma: Longer-Term Results of a Prospective Study.
    J Clin Endocrinol Metab. 2020 Oct 22. pii: 5936021. doi: 10.1210.
    PubMed    


    September 2020
  106. SHI X, Li CW, Tan LC, Wen SS, et al
    Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3 and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
    J Clin Endocrinol Metab. 2020 Sep 30. pii: 5916419. doi: 10.1210.
    PubMed     Abstract available


  107. RINGEL MD
    New Horizons: Emerging Therapies and Targets in Thyroid Cancer.
    J Clin Endocrinol Metab. 2020 Sep 25. pii: 5911817. doi: 10.1210.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: